# Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure

Study · id `cardio:ct-nct07460505` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07460505](<https://clinicaltrials.gov/study/NCT07460505>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07460505

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 328 participants.

## Technical summary

Registry record NCT07460505. Randomized; triple masking; primary purpose treatment. Start 2026-05-01 (anticipated); primary completion 2031-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 328 participants (planned count; ClinicalTrials.gov record NCT07460505, source copy `cardio:ctgov-nct07460505-2026-03-10`, retrieved 2026-10-26)
- Planned start: 2026-05-01 (anticipated) (ClinicalTrials.gov record NCT07460505, source copy `cardio:ctgov-nct07460505-2026-03-10`, retrieved 2026-10-26)
- Primary completion: 2031-04-01 (anticipated) (ClinicalTrials.gov record NCT07460505, source copy `cardio:ctgov-nct07460505-2026-03-10`, retrieved 2026-10-26)
- Completion: 2031-04-01 (anticipated) (ClinicalTrials.gov record NCT07460505, source copy `cardio:ctgov-nct07460505-2026-03-10`, retrieved 2026-10-26)
- Countries: Singapore (ClinicalTrials.gov record NCT07460505, source copy `cardio:ctgov-nct07460505-2026-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07460505-2026-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure
- Acronym: MARVEL-HF
- Condition: Heart Failure
- Condition: OSA - Obstructive Sleep Apnea
- Intervention (Device): Mandibular advancement device
- Intervention (Device): Mandibular advancement device (Sham)
- Lead sponsor: National University Hospital, Singapore
- Lead sponsor class: OTHER
- Collaborator: Alexandra Hospital
- Collaborator class: OTHER
- Collaborator: Ng Teng Fong General Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: National University Hospital, Singapore (`cardio:org-national-university-hospital-singapore`)
- Registry lists this organization as a collaborator: Alexandra Hospital (`cardio:org-alexandra-hospital`)
- Registry lists this organization as a collaborator: Ng Teng Fong General Hospital (`cardio:org-ng-teng-fong-general-hospital`)

## Provenance

Content hash: ecc1bca1b30c038c5c2e27ac36fe2b598b18a3a5c5c6b81a20a8f65e9bbd95ae
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
